kabutan

Welby Inc.(4438) Summary

4438
TSE Growth
Welby Inc.
280
JPY
-3
(-1.06%)
Dec 5, 3:30 pm JST
1.81
USD
Dec 5, 1:30 am EST
Result
PTS
outside of trading hours
281.1
Dec 5, 3:19 pm JST
Summary Chart Historical News Financial Result
PER
PBR
6.74
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
283 JPY 1.82 USD
Previous Close Dec 4
283 JPY 1.82 USD
High Dec 5, 9:00 am
283 JPY 1.82 USD
Low Dec 5, 2:56 pm
280 JPY 1.81 USD
Volume
11,100
Trading Value
3.00M JPY 0.02M USD
VWAP
281.14 JPY 1.82 USD
Minimum Trading Value
28,000 JPY 181 USD
Market Cap
2.32B JPY 0.02B USD
Number of Trades
35
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
143
1-Year High Mar 21, 2025
4,695
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 248,600
Nov 21, 2025 0 274,600
Nov 14, 2025 0 311,800
Nov 7, 2025 0 180,200
Oct 31, 2025 0 179,900
Company Profile
Welby Inc. provides personal health management platforms for lifestyle-related diseases and other conditions, primarily serving pharmaceutical companies, medical institutions, and healthcare-related organizations.
Sector
Information & Communication
Welby Inc. develops and operates PHR (Personal Health Record) platform services to support self-management for patients with lifestyle-related diseases and various other conditions. The company primarily works on commission from pharmaceutical companies to develop and manage platforms that promote proper use of new drugs and raise disease awareness upon market launch. Additionally, through its proprietary service "Welby MyKarte," the company supports self-management for patients with lifestyle-related diseases. These services facilitate information sharing between patients and healthcare professionals, contributing to treatment continuity and promoting self-health management. Revenue primarily consists of service development fees and usage fees from pharmaceutical companies, as well as charges to health insurance associations and corporations. With patient consent, accumulated data is also made available for sharing with healthcare professionals and for academic purposes.